Return to: Department of Medicine : Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Whats Inside
Message from the Director

Faculty

Fellowship Program

Research

Conferences

UMMC ID Clinic

International Programs

Make a Gift

Related Links

 

IDIM Home

Home > Faculty > University of Minnesota Medical Center > Bohjanen, Paul

Printer-friendly version   Mail this page to a friend

Bohjanen, Paul


 Dr. Paul Bohjanen

Paul R. Bohjanen, M.D., Ph.D., Associate Professor of Medicine and Associate Professor of Microbiology, has been a faculty member in the Division of Infectious Diseases and International Medicine since 2000.  He graduated from the University of Michigan with an M.D., Ph.D. degree in 1993 and then completed an internal medicine residency in 1997 and an infectious diseases fellowship in 2000, both at Duke University. Dr. Bohjanen has a clinical interest in HIV infection and the global AIDS epidemic.  His laboratory research is directed at understanding the regulation of gene expression in normal and virus-infected T lymphocytes.

For information about Dr. Bohjanen's research, click here to go to his laboratory’s web page.

Selected Publications:

P.R. Bohjanen and M.A. Sande.  2005.  HIV immune reconstitution syndrome:  An emerging problem in resource-poor regions.  Contagion.  2: 117-119.

P. Bohjanenand M. Sadigh. 2004.  Chapter 2, Basic Science: Basic Immunology, pp 23-33, in HIV/AIDS Training Program for Medical Doctors in Africa, M. Kamya and M. Scheld, Eds., Makerere University, Kampala, Uganda.

P. Bohjanenand G. Taylor.  2004.  Chapter 5, Antiretroviral Therapy and Management: Drug Toxicities, pp 388-397, in HIV/AIDS Training Program for Medical Doctors in Africa, M. Kamya and M. Scheld, Eds., Makerere University, Kampala, Uganda.

P.R. Bohjanen, M.D. Johnson, L.A. Szczech, D.W. Wray, W.P. Petros, C.R. Miller, and C.B. Hicks.  2002.  Steady state pharmacokinetics of lamivudine in HIV-infected patients with end-stage renal disease.  Antimicrob Agents Chemother.  46:2387-2392.

M. Gottfredsson and P.R. Bohjanen.  1997.  Human immunodeficiency virus type 1 as a target for gene therapy.  Frontiers in Bioscience.  2:d619-634.

P.R. Bohjanen, Y. Liu, and M.A. Garcia-Blanco.  1997.  TAR RNA decoys inhibit Tat-activated HIV-1 transcription after pre-initiation complex formation.  Nucleic Acids Res. 25:4481-4486.

C. Sune, P.R. Bohjanen, Y. Liu, and M.A. Garcia-Blanco.  1997.  Chapter 1:  The Tat-TAR RNP, a master switch that regulates HIV-1 gene expression.  In: Analysis of mRNA Formation and Function.  Ed. by J.D. Richter. Academic Press, San Diego.  pp1-21.

P.R. Bohjanen, R.A. Colvin, M. Puttaraju, M.D. Been, and M.A. Garcia-Blanco.  1996.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.  Nucleic Acids Res.  24:3733-3739.


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.